Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 7, 2018; 24(5): 623-630
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.623
Published online Feb 7, 2018. doi: 10.3748/wjg.v24.i5.623
Table 2 Phenotypes by Montreal classification
| n (%) | |
| Age at diagnosis | |
| A1 (≤ 16) | 56 (13.63) |
| A2 (17-40) | 296 (72.57) |
| A3 (> 40) | 60 (14.6) |
| Disease location | |
| L1 ileal | 279 (67.71) |
| L2 colonic | 2 (0.485) |
| L3 ileocolonic | 131 (31.87) |
| L4 upper GI disease | 50 (12.17) |
| p perianal disease | 125 (30.41) |
| Disease behavior | |
| B1 non-stricturing, non-penetrating | 35 (08.49) |
| B2 stricturing | 167 (40.63) |
| B3 penetrating | 197 (47.93) |
- Citation: Gathungu G, Zhang Y, Tian X, Bonkowski E, Rowehl L, Krumsiek J, Nix B, Chalk C, Trapnell B, Zhu W, Newberry R, Denson L, Li E. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn’s disease. World J Gastroenterol 2018; 24(5): 623-630
- URL: https://www.wjgnet.com/1007-9327/full/v24/i5/623.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i5.623